At 24 weeks, the control mice showed no tumor development, whereas approximately 63.6% of the ZNF498-overexpressing mice presented tumor development (Fig. 2B-E; Supplementary Fig. S2B). The gene discussed is ZSCAN25; the disease is neoplasm.